Nass Valley Gateway Ltd Enters Strategic Partnership With New Hope Labs to Heighten Scalability...
In a Move to Be Among the Industry's Leading Natural Seed Hemp Growers in the World, Company Gains Access to Significant Farming Acreage and Manufacturing Capabilities to...
NervGen Pharma Announces Departure of Chief Operating Officer
LifeSci Advisors Engaged to Provide Investor Relations ServicesVancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
NervGen Pharma Announces Departure of Chief Operating Officer
LifeSci Advisors Engaged to Provide Investor Relations ServicesVancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
AWAKN Life Sciences Launches Clinical Research Division with Prof. David Nutt & Dr. Ben...
Toronto, Ontario--(Newsfile Corp. - September 8, 2020) - AWAKN Life Sciences Inc ("AWAKN"), the European psychedelic assisted psychotherapy company, today announces the launch of its Commercial...
VitalHub Corp. Announces Strategic Private Placement
Toronto, Ontario--(Newsfile Corp. - September 3, 2020) - VITALHUB CORP. (TSXV: VHI) (the "Company" or "VitalHub"), is pleased to announce that it intends to complete a non-brokered...
Dr. Matthew Johnson Joins AWAKN Life Sciences
Professor of Psychiatry and Behavioural Sciences at Johns Hopkins Appointed as Member of Scientific Advisory BoardToronto, Ontario--(Newsfile Corp. - September 2, 2020) - AWAKN Life Sciences Inc....
Nass Valley Gateway Ltd. Redesigns Brand and Packaging to Reflect New Line of Premium...
National Wholesale and Retail Sales Efforts To Launch for Newly Rebranded Expanding Product Line of Top Quality, Broad and Full Spectrum CBD ConsumablesVancouver, British Columbia--(Newsfile Corp. -...
NervGen Pharma Reports Second Quarter 2020 Results
Phase 1 Clinical Study Remains on Track for Q4 2020Vancouver, British Columbia--(Newsfile Corp. - August 21, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or...
Novo Integrated Sciences Engages Maxim Group LLC to Assist with its Growth Strategy and...
Bellevue, Washington--(Newsfile Corp. - August 11, 2020) - Novo Integrated Sciences, Inc. (OTCQB: NVOS) ("Novo Integrated Sciences" or "the Company"), a provider of multi-dimensional primary healthcare...
NervGen Pharma Corp. Completes $6.45 Million Public Offering
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a biotech company dedicated to creating innovative solutions...